ID: ALA1092792

Max Phase: Preclinical

Molecular Formula: C7H8N2O2S

Molecular Weight: 184.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)O/N=C(\C)c1nccs1

Standard InChI:  InChI=1S/C7H8N2O2S/c1-5(9-11-6(2)10)7-8-3-4-12-7/h3-4H,1-2H3/b9-5+

Standard InChI Key:  ASUHRTXLUOGIRA-WEVVVXLNSA-N

Associated Targets(Human)

Putative hydrolase RBBP9 66 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 184.22Molecular Weight (Monoisotopic): 184.0306AlogP: 1.43#Rotatable Bonds: 2
Polar Surface Area: 51.55Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 1.48CX LogP: 0.72CX LogD: 0.72
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.40Np Likeness Score: -0.90

References

1. Bachovchin DA, Wolfe MR, Masuda K, Brown SJ, Spicer TP, Fernandez-Vega V, Chase P, Hodder PS, Rosen H, Cravatt BF..  (2010)  Oxime esters as selective, covalent inhibitors of the serine hydrolase retinoblastoma-binding protein 9 (RBBP9).,  20  (7): [PMID:20207142] [10.1016/j.bmcl.2010.02.011]

Source